SEC Filings | Connect Biopharma Holdings Ltd

Filing date	Form	Description	Filing Group	View
July 11, 2022	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001193125-22-191285.pdf 0001193125-22-191285.rtf 0001193125-22-191285.xls View HTML
July 6, 2022	EFFECT	EFFECT	Other	9999999995-22-001972.pdf 9999999995-22-001972.rtf 9999999995-22-001972.xls View HTML
July 1, 2022	S-8	Securities offered to employees pursuant to employee benefit plans	Registration Statements	0001193125-22-187309.pdf 0001193125-22-187309.rtf 0001193125-22-187309.xls View HTML
July 1, 2022	CORRESP	CORRESP	Other	0001193125-22-187203.pdf 0001193125-22-187203.rtf 0001193125-22-187203.xls View HTML
June 17, 2022	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001193125-22-176494.pdf 0001193125-22-176494.rtf 0001193125-22-176494.xls View HTML
June 17, 2022	F-3/A	Amendment to a previously filed F-3	Registration Statements	0001193125-22-176648.pdf 0001193125-22-176648.rtf 0001193125-22-176648.xls View HTML
June 17, 2022	CORRESP	CORRESP	Other	0001193125-22-176651.pdf 0001193125-22-176651.rtf 0001193125-22-176651.xls View HTML
June 10, 2022	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001193125-22-171423.pdf 0001193125-22-171423.rtf 0001193125-22-171423.xls View HTML
June 3, 2022	UPLOAD	UPLOAD	Other	0000000000-22-006019.pdf 0000000000-22-006019.rtf View HTML
May 23, 2022	F-3/A	Amendment to a previously filed F-3	Registration Statements	0001193125-22-156426.pdf 0001193125-22-156426.rtf 0001193125-22-156426.xls View HTML

Data provided by Kaleidoscope.